Arca
Skip to content

AGTR1: Type-1 angiotensin II receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Receptor for angiotensin II, a vasoconstricting peptide, which acts as a key regulator of blood pressure and sodium retention by the kidney.

  • Drugs that act on it: 18
  • With a US drug page: 10
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
Angiotensin iiApprovedType-1 angiotensin II receptor agonistAgonist—
Candesartan cilexetilApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
EprosartanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
IrbesartanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
LosartanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
Olmesartan medoxomilApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
SaralasinApprovedType-1 angiotensin II receptor antagonistAntagonist—
SparsentanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
TelmisartanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
ValsartanApprovedType-1 angiotensin II receptor antagonistAntagonistBoxed warning
Azilsartan—Type-1 angiotensin II receptor antagonistAntagonist—
Azilsartan medoxomil—Type-1 angiotensin II receptor antagonistAntagonistBoxed warning
Candesartan—Type-1 angiotensin II receptor antagonistAntagonist—
Fimasartan—Type-1 angiotensin II receptor antagonistAntagonist—
Olmesartan—Type-1 angiotensin II receptor antagonistAntagonist—
Pratosartan—Type-1 angiotensin II receptor antagonistAntagonist—
Tasosartan—Type-1 angiotensin II receptor antagonistAntagonist—
TRV-120027—Type-1 angiotensin II receptor antagonistAntagonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Renal tubular dysgenesis
0.75
Hypertensive disorder
0.74
Renal tubular dysgenesis of genetic origin
0.72
Essential hypertension, genetic
0.61
Congestive heart failure
0.61
Kidney disorder
0.61
Stroke disorder
0.60
Cardiovascular disorder
0.59

Drugs and mechanisms are from ChEMBL CHEMBL227 (CC BY-SA 3.0). Gene name, function (UniProt P30556, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.